Orion Q1 Sales Up, Shares Fall 4.3%

Orion Corp Q1 net sales rose 17.8% YoY to EUR 417.7 million, with operating profit and EPS up 47% each.
Despite the strong results, Orion shares fell 4.3% after the company raised its 2026 guidance range for sales and profit.
New 2026 outlook targets EUR 1.95‑2.10 billion net sales and EUR 600‑750 million operating profit, with higher R&D and marketing spend.
Growth was driven by higher royalties and Nubeqa sales, Easyhaler combo‑therapy gains, and faster Consumer Health expansion versus Generics.